chr12-80211953-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP6
The NM_001378609.3(OTOGL):c.124G>A(p.Gly42Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000079 in 1,569,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G42G) has been classified as Benign.
Frequency
Consequence
NM_001378609.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTOGL | NM_001378609.3 | c.124G>A | p.Gly42Arg | missense_variant | 4/59 | ENST00000547103.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTOGL | ENST00000547103.7 | c.124G>A | p.Gly42Arg | missense_variant | 4/59 | 5 | NM_001378609.3 | P1 | |
OTOGL | ENST00000646859.1 | c.124G>A | p.Gly42Arg | missense_variant | 9/63 | ||||
OTOGL | ENST00000643417.1 | n.784G>A | non_coding_transcript_exon_variant | 7/23 |
Frequencies
GnomAD3 genomes AF: 0.000454 AC: 69AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000790 AC: 15AN: 189892Hom.: 0 AF XY: 0.0000684 AC XY: 7AN XY: 102302
GnomAD4 exome AF: 0.0000381 AC: 54AN: 1417324Hom.: 0 Cov.: 30 AF XY: 0.0000385 AC XY: 27AN XY: 702146
GnomAD4 genome AF: 0.000460 AC: 70AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.000483 AC XY: 36AN XY: 74458
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Jul 19, 2022 | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 33 of the OTOGL protein (p.Gly33Arg). This variant is present in population databases (rs149117887, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with OTOGL-related conditions. ClinVar contains an entry for this variant (Variation ID: 1211910). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The arginine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 14, 2022 | The c.97G>A (p.G33R) alteration is located in exon 3 (coding exon 3) of the OTOGL gene. This alteration results from a G to A substitution at nucleotide position 97, causing the glycine (G) at amino acid position 33 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at